All Insights

GLG는 전세계 100만명 이상의 자문위원을 보유하고 있습니다. 하기 각 전문가들의 사례를 참고하시기 바랍니다.

Insight Type: 모두
모두기사사례연구비디오Bright Papers (White Papers)Podcasts
What Does the Future Hold for the GOP after Trump?
기사

What Does the Future Hold for the GOP after Trump?

U.S. Election
Data Privacy Legislation and Digital Advertising
기사

Data Privacy Legislation and Digital Advertising

Advertising, Legislation, Media and Entertainment, Technology and Telecom
Microsoft’s Leading Edge in the Cloud Gaming Space
기사

Microsoft’s Leading Edge in the Cloud Gaming Space

Cloud, Gaming, Technology and Telecom
What Will Keep Companies Ahead in the ‘New Normal’
기사

What Will Keep Companies Ahead in the ‘New Normal’

Coronavirus, New Normal, Corporate Firm Resources
eBook: A Fast Guide to Conjoint Analysis
기사

eBook: A Fast Guide to Conjoint Analysis

Best Practices, Expert Insights, Survey Best Practices, Surveys, GLG Surveys and Qualitative Research
Types of Survey Questions and When to Use Them
기사

Types of Survey Questions and When to Use Them

Best Practices, Survey Best Practices, Surveys, GLG Surveys and Qualitative Research
The GLG CEO Survey 2021: A Positive Outlook for the Year
기사

The GLG CEO Survey 2021: A Positive Outlook for the Year

CEO Survey, Executive Surveys, Surveys, GLG Surveys and Qualitative Research, Global Economy
GLG Close-Up on Incoming Biden Staffers
기사

GLG Close-Up on Incoming Biden Staffers

Biden, U.S. Election, U.S. Politics, Global Politics
Streaming Video Likely Permanently Damaged the Cinema Business
기사

Streaming Video Likely Permanently Damaged the Cinema Business

Healthcare Leadership: 3 Takeaways from 2020
기사

Healthcare Leadership: 3 Takeaways from 2020

industry insights, Healthcare and Life Sciences
Survey: How Is the Global Market Preparing for Hydrogen Deployment?
기사

Survey: How Is the Global Market Preparing for Hydrogen Deployment?

Green Energy, Hydrogen, Surveys, Energy and Industrials, GLG Surveys and Qualitative Research
Covid-19 Vaccines and Therapeutics: Where We Stand Now
기사

Covid-19 Vaccines and Therapeutics: Where We Stand Now

Coronavirus, Therapeutics, Vaccines, Healthcare and Life Sciences